Related Experiment Video
Updated: Jun 1, 2026

The Use of Reverse Phase Protein Arrays (RPPA) to Explore Protein Expression Variation within Individual Renal Cell Cancers
Published on: January 22, 2013
Resistance proteins in human kidney, breast, ovarian and lung-carcinoma - a comparative-analysis
U Masanek1, E Pommerenke, J Mattern
1GERMAN CANC RES CTR,DEPT 0511,NEUENHEIMER FELD 280,D-69120 HEIDELBERG,GERMANY.
Abstract:
The expression of P-glycoprotein (P-170), glutathione S-transferase-pi (GST-pi), dihydrofolate reductase (DHFR) and thymidylate synthase (TS) was analyzed immunohistochemically in human tumors of different origin. The resistance proteins were expressed at varying degree: all kidney carcinomas (n=25), 40 of 56 non-small cell lung carcinomas (NSCLC) (71%), 8 of 15 ovarian carcinomas (53%), 5 of 11 breast carcinomas (46%) and 3 of 14 small cell lung carcinomas (SCLC) (21%) expressed more than one resistance protein. A comparison of the immunohistochemical data with the clinical response rates as reported in literature, demonstrates an evident correlation between the number of resistance proteins and the clinical outcome.
Related Concept Videos
Treatment Resistant Cancers
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

